Sign in
Stories
Assertio Holdings Faces Securities Lawsuit
Share
Alleged Investor Misconduct Lawsuits Ale...
Alleged Misconduct Spurs Class Actions
Assertio Acquires Spectrum Pharmaceutica...
AVXL Lawsuit: Deceptive Practices Expose...
Altimmune Faces Investor Investigation
Anavex Lawsuit Over Blarcamesine Trials
Overview
API
A securities class action lawsuit has been filed against Assertio Holdings, Inc. by Kessler Topaz Meltzer & Check, LLP, citing violations of securities laws and misleading statements resulting in investor losses. The approval of a generic version of Assertio's product by Zydus Lifesciences Limited led to a lowered financial outlook and a stock price decline.
Ask a question
How might the outcome of the class action lawsuit impact Assertio Holdings and its stakeholders?
In what ways can companies ensure transparency and compliance with securities laws to avoid similar legal actions?
What strategies could Assertio implement to recover from the financial implications of the generic product approval?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Nov 2023
Dec 2023
Jan 2024
Coverage